There are currently 84 active clinical trials seeking participants for Atrial Fibrillation research studies. The states with the highest number of trials for Autism participants are Florida, California, Ontario and Texas.
The Vanderbilt Atrial Fibrillation Ablation Registry
NCT02404415
Recruiting
The Vanderbilt Atrial Fibrillation Ablation registry (VAFAR) is a prospective clinical and genetic biorepository that systematically enrolls patients undergoing atrial fibrillation (AF) ablation. The registry was started in 2011 and has greater than 1000 AF ablation records with stored blood and DNA samples. The goals of VAFAR are to: 1) identify clinical, genetic, and serological predictors of response to AF ablation in order to improve patient selection, and 2) to provide a resource for transl... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
03/02/2024
Locations: Vanderbilt University Medical Center, Nashville, Tennessee
Conditions: Atrial Fibrillation
Register for Updates
RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.
NCT05883631
Recruiting
Demonstrate the safety and effectiveness of the Ablacath™ Mapping Catheter and Ablamap® System in patients with all types of atrial fibrillation (AF) including paroxysmal or persistent or long-standing persistent, undergoing and De Novo or Redo procedures. Phenotype patients and demonstrate the prognostication power of Electrographic Flow (EGF®) maps among all subjects using 12-month follow-up outcomes following EGF-guided mapping and ablation.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
02/28/2024
Locations: Banner Health, Phoenix, Arizona +19 locations
Conditions: Atrial Fibrillation, Atrial Fibrillation, Persistent, Atrial Fibrillation Paroxysmal, Arrhythmia, Arrhythmias, Cardiac, Atrial Flutter, Atrial Fibrillation, Paroxysmal or Persistent, Atrial Arrhythmia, Atrial Tachycardia
Register for Updates
EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)
NCT03950076
Recruiting
To assess whether edoxaban (60/30 mg daily) compared to non-antithrombotic medical therapy (either no antithrombotic therapy or antiplatelet monotherapy) reduces the risk of stroke (composite of ischemic, hemorrhagic and unspecified stroke) in high-risk atrial fibrillation (CHA2DS2-VASc ≥2) patients with previous intracranial hemorrhage.
Gender:
All
Ages:
45 years and above
Trial Updated:
02/27/2024
Locations: Alexian Brothers Medical Center, Elk Grove Village, Illinois +152 locations
Conditions: Intracranial Hemorrhages, Atrial Fibrillation
Register for Updates
SmartWatch ECG Evaluation Trial I
NCT05942274
Recruiting
This is a single-center, non-randomized study to collect validation data for submission to the Food and Drug Administration (FDA) to support a 510(k) device clearance for a smartwatch ECG.
Gender:
All
Ages:
Between 18 years and 90 years
Trial Updated:
02/26/2024
Locations: University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
Conditions: Atrial Fibrillation
Register for Updates
STrategies for Catheter Ablation of peRsistent Atrial Fibrlllation
NCT04428944
Recruiting
The objective of this study is to compare the efficacy of three different ablation strategies in patients with persistent AF: PV antral isolation alone (PVAI) PV antral isolation plus ablation of drivers (PVAI+drivers) PV antral isolation plus isolation of posterior wall (PVAI+box) All three strategies will employ contemporary catheter ablation technology using more efficient open irrigated tip cooling and contact force sensing.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/22/2024
Locations: Brigham & Women'S Hosptial Inc., Boston, Massachusetts +31 locations
Conditions: Atrial Fibrillation
Register for Updates
The Effect of Different Low-Level Tragus Stimulation Parameters On Autonomic Nervous System Function
NCT04682704
Recruiting
Low level transcutaneous vagus nerve stimulation (LLTS) involves delivery of electrical impulses transcutaneously at the auricular branch of vagus nerve and it has been shown to have anti-inflammatory and anti-arrhythmic effects. In previous studies from our laboratory, we found that LLTS significantly suppressed atrial fibrillation (AF) inducibility and decreased AF duration. The anti-arrhythmic effects of LLTS were similar to those delivered to the cervical VN trunk. LLTS for just one hour sig... Read More
Gender:
All
Ages:
Between 21 years and 90 years
Trial Updated:
02/19/2024
Locations: University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
Conditions: Atrial Fibrillation, Heart Failure, Diastolic
Register for Updates
Get With the Guidelines Atrial Fibrillation Registry
NCT06245187
Recruiting
Get With The Guidelines-Atrial Fibrillation is designed to assist hospital care teams in consistently providing the latest evidence-based treatment for their AFib patients. At the same time, it offers a means of monitoring the quality of AFib care in U.S. hospitals and building a database for continued research and further quality improvement.
Gender:
All
Ages:
Between 18 years and 125 years
Trial Updated:
01/29/2024
Locations: Kelly Burlison, Dallas, Texas
Conditions: Atrial Fibrillation, Atrial Flutter
Register for Updates
MANAGE-AF Registry -MANAGEment of Atrial Fibrillation Outcomes Registry (MANAGE-AF)
NCT05978466
Recruiting
The purpose of this research is to learn more about the normal care of patients with a new or pre-existing diagnosis of atrial fibrillation (AF). These abnormal and irregular heartbeats place patients at increased risk of developing clots in their bloodstream that could potentially lead to stroke. Normal care is designed to help prevent this from happening and to lessen or eliminate the symptoms patients may have. There are many different types of AF as well as numerous ways in which a variety o... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
01/17/2024
Locations: CorVita Science Foundation (NFP), Chicago, Illinois
Conditions: Atrial Fibrillation
Register for Updates
Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AF
NCT06099730
Recruiting
The primary objective of this clinical investigation is to demonstrate the safety and 12-month effectiveness of pulmonary vein isolation (PVI) and posterior LA wall isolation in the treatment of subjects with symptomatic paroxysmal and persistent atrial fibrillation using the pulsed field ablation with the VARIPULSE™ catheter and the TRUPULSE™ generator.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
01/11/2024
Locations: Massachusetts General Hospital, Boston, Massachusetts
Conditions: Atrial Fibrillation
Register for Updates
Metformin as an Adjunctive Therapy to Catheter Ablation in Atrial Fibrillation
NCT04625946
Recruiting
This clinical trial is being done to determine if metformin, a drug which is normally used in diabetes, can reduce atrial fibrillation in patients who are having an ablation for atrial fibrillation (AF). Atrial fibrillation is an abnormal heart rhythm which research has shown is related in part to obesity and diabetes. It is anticipated that the participants treated in the metformin arm will have greater freedom from recurrent atrial arrhythmias after ablation. Eligible participants enrolled i... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
01/09/2024
Locations: University of Michigan, Ann Arbor, Michigan
Conditions: Atrial Fibrillation
Register for Updates
Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease
NCT05442203
Recruiting
Atrial fibrillation is an abnormal beating of the heart that can lead to stroke or heart failure. Structural heart diseases are conditions that affect the heart valves or heart muscle and can cause permanent heart damage if left untreated. Sometimes people have atrial fibrillation or structural heart disease and do not know it. The purpose of this study is to evaluate two devices that can predict who has or may develop atrial fibrillation or structural heart disease based on the results of an el... Read More
Gender:
All
Ages:
40 years and above
Trial Updated:
01/04/2024
Locations: Corewell Health, Grand Rapids, Michigan +2 locations
Conditions: Atrial Fibrillation, Structural Heart Disease
Register for Updates
Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors
NCT05643235
Recruiting
This study will enroll patients initiating Bruton Tyrosine Kinase (BTK) inhibitors without history of documented arrhythmia while on therapy using the Medtronic LINQ-2 insertable cardiac monitor (ILR). The incidence of new onset atrial fibrillation (AF) and other arrhythmia will be determined. Actions taken in response to device detected arrhythmia will be recorded.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/03/2024
Locations: Northwell (Northshore University/Long Island Jewish Hospitals), New Hyde Park, New York
Conditions: Atrial Fibrillation, Supraventricular Arrhythmia, Ventricular Arrhythmias and Cardiac Arrest, Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Register for Updates